Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes Phase 1/Phase 2 studies to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer

Drugs mentioned

• BMS-986507

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lung Cancer, Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING